PP-14, a Novel Structurally-Enhanced Antisickling Allosteric Hemoglobin Effector, Increases Oxygen Affinity and Disrupts Hemoglobin S Polymer Formation
Martin K. Safo(Virginia Commonwealth University), Osheiza Abdulmalik(Children's Hospital of Philadelphia), Nancy Anabaraonye(Children's Hospital of Philadelphia), Xiaomeng Xu(Shanghai Jiao Tong University), Stefano Rivella(Children's Hospital of Philadelphia), Valentina Ghiaccio(Children's Hospital of Philadelphia), Mohini S. Ghatge(Children's Hospital of Philadelphia), Patrick C. Hines, Piyusha P. Pagare(Virginia Commonwealth University), Ke Liu(Nanfang Hospital), Carla Casu(Children's Hospital of Philadelphia), Yan Zhang(Virginia Commonwealth University), Jürgen Venitz(National Cancer Institute)
Cited by 1
Related Papers
In vivo hematopoietic stem cell modification by mRNA delivery
|Science|2023|321
2‐Methoxyestradiol, a Promising Anticancer Agent
|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2003|276
5‐hydroxymethyl‐2‐furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells<sup>†,‡</sup>
|British Journal of Haematology|2005|244
Sphingosine-1-phosphate promotes erythrocyte glycolysis and oxygen release for adaptation to high-altitude hypoxia
|Nature Communications|2016|212
G Protein–Coupled Receptor Deorphanizations
|The Annual Review of Pharmacology and Toxicology|2011|193